Equillium, Inc. EQ
EQ
Equillium, Inc. CUE
Cue Biopharma, Inc. COEP
Coeptis Therapeutics, Inc. NRXP
NRx Pharmaceuticals, Inc. OSTX
OS Therapies Incorporated IPSC
Century Therapeutics, Inc. TELO
Telomir Pharmaceuticals, Inc. Common Stock OTLK
Outlook Therapeutics, Inc. FBIO
Fortress Biotech, Inc. SPRB
Spruce Biosciences, Inc.
Equillium, Inc. CUE
Cue Biopharma, Inc. COEP
Coeptis Therapeutics, Inc. NRXP
NRx Pharmaceuticals, Inc. OSTX
OS Therapies Incorporated IPSC
Century Therapeutics, Inc. TELO
Telomir Pharmaceuticals, Inc. Common Stock OTLK
Outlook Therapeutics, Inc. FBIO
Fortress Biotech, Inc. SPRB
Spruce Biosciences, Inc.
Performance
| Periode | EQ | CUE | COEP | NRXP | OSTX | IPSC | TELO | OTLK | FBIO | SPRB |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 177.18 % | -64.72 % | 29.55 % | -24.58 % | -13.10 % | 262.88 % | 20.87 % | -77.34 % | 88.83 % | 870.05 % |
| YTD | -24.84 % | -10.49 % | -13.46 % | -13.36 % | 8.96 % | 118.11 % | 3.73 % | -17.24 % | -7.69 % | -18.93 % |
| 1Y | 64.31 % | -76.41 % | 32.53 % | -46.71 % | -64.56 % | 139.73 % | -70.98 % | -75.06 % | 94.76 % | 155.93 % |
| 3Y | 6.48 % | -91.01 % | -66.83 % | -83.06 % | -41.83 % | -52.10 % | -80.14 % | -97.87 % | -76.15 % | -63.00 % |
| 5Y | -79.13 % | -97.94 % | -93.80 % | -99.30 % | -41.83 % | -90.49 % | -80.14 % | -97.83 % | -93.11 % | -95.66 % |
| 10Y | -91.79 % | -97.40 % | -93.60 % | -97.64 % | -41.83 % | -90.49 % | -80.14 % | -99.92 % | -89.40 % | -94.23 % |
| Depuis le début | -91.79 % | -97.40 % | -93.60 % | -97.64 % | -41.83 % | -90.49 % | -80.14 % | -99.92 % | -97.75 % | -94.23 % |